Actively Recruiting

Phase 3
Age: 2Years - 17Years
All Genders
Healthy Volunteers
NCT07013487

A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)

Led by Merck Sharp & Dohme LLC · Updated on 2026-05-12

12000

Participants Needed

40

Research Sites

332 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to demonstrate that V181 is safe and well tolerated, elicits an immune response, and reduces the frequency of virologically confirmed dengue (VCD) of any severity, due to any of the 4 dengue serotypes, regardless of dengue serostatus at baseline in children 2 to 17 years of age.

CONDITIONS

Official Title

A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)

Who Can Participate

Age: 2Years - 17Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants must be generally healthy based on medical history and physical examination.
  • Age between 2 and 17 years.
Not Eligible

You will not qualify if you...

  • Known or suspected immune system problems or immunodeficiency.
  • History of congenital or acquired immunodeficiency.
  • Documented HIV infection or breastfeeding from a mother with HIV.
  • History of hepatitis B or C infection.
  • Bleeding disorders that prevent subcutaneous vaccination or repeated blood draws.
  • Serious or progressive diseases such as cancer, uncontrolled diabetes, severe heart, kidney, or liver failure, or autoimmune or neurological disorders.
  • Known neurological or cognitive behavioral disorders including encephalitis, myelitis, or pervasive developmental disorders.
  • Previous dengue vaccination or plans to receive a dengue vaccine during the study (other than study vaccine).
  • Use of systemic corticosteroids within 30 days before vaccination or expected use within 28 days after.
  • Blood transfusion or blood products including immunoglobulins within 6 months before vaccination or planned use within 28 days after.
  • Use of immunosuppressive therapies such as chemotherapy or organ transplant treatments within 6 months before vaccination or planned use within 28 days after.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 40 locations

1

Jatinegara Primary Health Center ( Site 0102)

East Jakarta, Jakarta Special Capital Region, Indonesia, 13310

Actively Recruiting

2

Cipayung Primary Health Center ( Site 0105)

East Jakarta, Jakarta Special Capital Region, Indonesia, 13840

Actively Recruiting

3

Dr Cipto Mangunkusumo Hospital-Pediatrics ( Site 0101)

Jakarta, Jakarta Special Capital Region, Indonesia, 10430

Actively Recruiting

4

Kelapa Gading Primary Health Center ( Site 0104)

North Jakarta, Jakarta Special Capital Region, Indonesia, 14240

Actively Recruiting

5

Pasar Minggu Primary Health Center ( Site 0103)

South Jakarta, Jakarta Special Capital Region, Indonesia, 12620

Actively Recruiting

6

Hospital Pakar Kanak - Kanak UKM (HPKK) ( Site 0024)

Cheras, Kuala Lumpur, Malaysia, 56000

Completed

7

University Malaya Medical Centre-Department of Paediatrics ( Site 0025)

Lembah Pantai, Kuala Lumpur, Malaysia, 59100

Actively Recruiting

8

Hospital Sibu ( Site 0021)

Sibu, Sarawak, Malaysia, 96000

Actively Recruiting

9

Hospital Ampang ( Site 0028)

Ampang, Selangor, Malaysia, 68000

Actively Recruiting

10

Hospital Al-Sultan Abdullah - Universiti Teknologi MARA ( Site 0029)

Bandar Puncak Alam, Selangor, Malaysia, 42300

Completed

11

Sunway Medical Centre ( Site 0027)

Petaling Jaya, Selangor, Malaysia, 47500

Actively Recruiting

12

Hospital Tunku Azizah-Paediatric ( Site 0022)

Kuala Lumpur, Malaysia, 50300

Actively Recruiting

13

Health Index Multispecialty And Lying-In Clinic ( Site 0042)

Bacoor, Cavite, Philippines, 4102

Actively Recruiting

14

Chong Hua Hospital ( Site 0051)

Cebu City, Cebu, Philippines, 6000

Actively Recruiting

15

Norzel Medical and Diagnostic Clinic Foundation Corp ( Site 0044)

Cebu City, Central Visayas (Region VII), Philippines, 6000

Actively Recruiting

16

West Visayas State University Medical Center ( Site 0045)

Iloilo City, Iloilo, Philippines, 5000

Active, Not Recruiting

17

Philippine General Hospital ( Site 0041)

Manila, National Capital Region, Philippines, 1000

Actively Recruiting

18

University of the Philippines Manila ( Site 0047)

Metro Manila, National Capital Region, Philippines, 1000

Actively Recruiting

19

Clinical Research Investigator Group ( Site 0110)

Bayamón, Puerto Rico, 00960

Actively Recruiting

20

San Juan Bautista School of Medicine - Clinical Research Unit ( Site 0114)

Caguas, Puerto Rico, 00726

Actively Recruiting

21

Ponce Medical School Foundation Inc./CAIMED Center ( Site 0112)

Ponce, Puerto Rico, 00716

Actively Recruiting

22

Latin Clinical Trial Center ( Site 0113)

San Juan, Puerto Rico, 00909

Actively Recruiting

23

Wellness clinical Research Vega Baja ( Site 0116)

Vega Baja, Puerto Rico, 00693

Actively Recruiting

24

National University Hospital-Paediatrics ( Site 0001)

Singapore, Central Singapore, Singapore, 119074

Actively Recruiting

25

KK Women's and Children's Hospital ( Site 0002)

Singapore, Central Singapore, Singapore, 229899

Actively Recruiting

26

Tan Tock Seng Hospital ( Site 0003)

Singapore, Central Singapore, Singapore, 308433

Actively Recruiting

27

Chulalongkorn University-Pediatrics ( Site 0063)

Bangkok, Bangkok, Thailand, 10330

Actively Recruiting

28

Faculty of Tropical Medicine, Mahidol University ( Site 0062)

Bangkok, Bangkok, Thailand, 10400

Actively Recruiting

29

Queen Sirikit National Institute of Child Health-Pediatric Infectious Disease ( Site 0071)

Bangkok, Bangkok, Thailand, 10400

Actively Recruiting

30

Faculty of Medicine Siriraj Hospital-Pediatric Infectious Diseases ( Site 0065)

Bangkok, Bangkok, Thailand, 10700

Active, Not Recruiting

31

Faculty of Tropical Medicine, Mahidol University - Vaccine Trial Centre ( Site 0067)

Ratchathewi, Bangkok, Thailand, 10400

Actively Recruiting

32

Faculty of Medicine - Khon Kaen University-Pediatrics ( Site 0064)

Amphoe Mueang, Changwat Khon Kaen, Thailand, 40002

Actively Recruiting

33

Thammasat University Hospital-Department of Pediatrics ( Site 0068)

Khong Luang, Changwat Pathum Thani, Thailand, 12120

Actively Recruiting

34

Songklanagarind hospital-Department of Pediatrics ( Site 0061)

Hat Yai, Changwat Songkhla, Thailand, 90110

Actively Recruiting

35

Maharaj Nakorn Chiang Mai Hospital ( Site 0066)

Chiang Mai, Thailand, 50200

Actively Recruiting

36

Kien Giang Women's and Children hospital ( Site 0091)

Rach Gia, An Giang, Vietnam, 920 000

Actively Recruiting

37

Cai Lay Regional General Hospital ( Site 0093)

Cai Lậy, Tien Giang, Vietnam, 860 000

Actively Recruiting

38

Quang Nam Hospital for Women and Children ( Site 0094)

Da Nang, Vietnam, 550000

Actively Recruiting

39

Dong Thap General Hospital ( Site 0092)

Dong Thập, Vietnam, 810000

Actively Recruiting

40

Pasteur Institute in Ho Chi Minh city ( Site 0089)

Ho Chi Minh City, Vietnam, 70000

Actively Recruiting

Loading map...

Research Team

T

Toll Free Number

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here